Table 3.
Bone lymphoma incidence-based mortality trends by demographic and tumor characteristics (diagnosed 1985–2016).
| Characteristic | Overall, (1985–2016) |
|
|---|---|---|
| APC, % (95% CI) | P-value | |
| Overall | 1.5 (1.3–1.7) | <0.05 |
| Age, y | ||
| 0–19 | −1.7 (−2.7 to −0.7) | <0.05 |
| 20–39 | 0.4 (−0.4 to 1.3) | 0.3 |
| 40–59 | 1.7 (0.8 to 2.5) | <0.05 |
| ≥60 | 2.1 (1.7 to 2.5) | <0.05 |
| Sex | ||
| Male | 1.5 (1.1 to 1.9) | <0.05 |
| Female | 1.4 (1.0 to 1.9) | <0.05 |
| Race | ||
| White | 1.4 (1.3 to 1.6) | <0.05 |
| Black | 3.2 (2.1 to 4.3) | <0.05 |
| Others | 0.8 (−0.5 to 2.2) | 0.2 |
| Unknown | NA | NA |
| SEER Historic Stage A | ||
| Localized | 1.1 (0.6 to 1.6) | <0.05 |
| Regional | 0.3 (−0.2 to 0.8) | 0.2 |
| Distant | 2.9 (2.3 to 3.5) | <0.05 |
| Unknown | NA | NA |
| Tumor Location | ||
| Appendicular | 0.5 (0.0 to 1.0) | <0.05 |
| Axial | 2.0 (1.6 to 2.5) | <0.05 |
| Unknown | NA | NA |
| Histologic Type | ||
| DLBCL | 2.3 (1.2 to 3.5) | <0.05 |
| Other NPL | 3.7 (2.9 to 4.5) | <0.05 |
| Others and unclassified | NA | NA |
Abbreviations: APC, annual percent change; CI, confidence interval; NA, not applicable; DLBCL, diffuse large B-cell lymphomas; NPL, non-Hodgkin’s lymphoma; SEER, Surveillance, Epidemiology, and End Results.